SMARCB1/INI1 exon amplification and sequencing revealed the presence of a homozygous exon 2 c.118C>T (Arg40X) mutation in both the primary and metastatic tumor lesions (Figure 3A). This evidence concerns the gene SMARCB1 and metastatic neoplasm.